The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow Corp. is a U.S.-based, public benefit corporation committed to solving America’s broken essential medicine supply chain. This award recognizes Phlow for its performance during the previous fiscal year on its contract with HHS.
Updates From Phlow™
Phlow Corp. CFO Receives Virginia Business CFO Award
Phlow is honored to announce that our CFO, Bob Mooney, has received the coveted Virginia Business CFO Award honoring chief financial executives in Virginia.
Phlow Corporation Donates to Pleasants Lane Elementary in Petersburg
Phlow Corporation was honored to present, alongside our partners, AMPAC Fine Chemicals, Civica Rx, and Virginia Commonwealth University Medicines For All Institute, a check for over $58,000 on June 17, 2021 to Pleasants Lane Elementary in Petersburg, Virginia to rebuild their playground.
Phlow Corporation Supports Biden Administration Efforts to Strengthen the Pharmaceutical Supply Chain
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages
RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...
Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients
Phlow and the United States Pharmacopeia have formed a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines.
Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives
This injection of additional strategic capital will further enhance Phlow’s mission to reimagine the end-to-end domestic production critical to U.S. healthcare.
Congresswoman Spanberger Tours Phlow Corp, Focuses on Strengthening Domestic Supply Chain & Bringing High-Paying Jobs to Central Virginia
Phlow demonstrates a 100% U.S.-based and fully integrated solution that will have an extraordinary impact on the lives of patients and families for decades to come.
Advanced Pharmaceutical Manufacturing Campus in Central Virginia Will Create 186 New Jobs in City of Petersburg
A unique partnership between Civica Rx, Phlow, VCU’s Medicines for All Institute, and AMPAC Fine Chemicals to ensure every American will have access to essential medicines.
Phlow Co-Founder Featured in Life Science Leader
Revolutionizing Pharma Manufacturing From The Outside In